Friedeborg Seitz

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Emergency Department

Chronic Obstructive Pulmonary Disease

Randomized Controlled Trial

Top Venues

Clinical and translational science

Naunyn-Schmiedeberg's archives of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Philipp Badorrek, Claudia Diefenbach, Harald Kögler, Anastasia Eleftheraki, Friedeborg Seitz, Jens M Hohlfeld
Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: Phase I characterization in healthy volunteers. Clinical and translational science 17 (8) (2024)
Diane Wong, Friedeborg Seitz, Verena Bauer, Thomas Giessmann, Friedrich Schulze
Safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 685509, a soluble guanylyl cyclase activator, in healthy volunteers: Results from two randomized controlled trials. Naunyn-Schmiedeberg's archives of pharmacology (2024)
Philipp Badorrek, Claudia Diefenbach, Harald Kögler, Anastasia Eleftheraki, Friedeborg Seitz, Jens M Hohlfeld
Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: Phase I characterization in healthy volunteers. Clinical and translational science 17 (8) (2024)
Philipp Badorrek, Claudia Diefenbach, Harald Kögler, Anastasia Eleftheraki, Friedeborg Seitz, Jens M Hohlfeld
Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: Phase I characterization in healthy volunteers. Clinical and translational science 17 (8) (2024)